Literature DB >> 7759856

Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats.

N Hirawa1, Y Uehara, Y Kawabata, A Numabe, N Ohshima, H Ono, T Gomi, T Ikeda, S Yagi, T Toyo-oka.   

Abstract

OBJECTIVE: To investigate the effects of subpressor doses of angiotensin II (Ang II) on the progression of renal injuries in Dahl salt-sensitive (Dahl-S) rats with hypertension.
METHODS: Rats were fed a high-salt (4% NaCl) diet and given an Ang II infusion (10 or 50 ng/kg per min, subcutaneously) for 4 weeks.
RESULTS: The plasma Ang II concentration achieved in the high-dose Ang II infusion was lower than that in low-salt (0.3% NaCl) normotensive rats. The Ang II infusion did not affect systolic blood pressure, cardiac hypertrophy or weight of thoracic aorta. However, the high-dose Ang II infusion increased proteinuria by 58%, enhanced the urinary N-acetyl-beta-D-glucosaminase index by 77% and reduced the glomerular filtration rate by 37%. The impaired renal function was associated with a progression of glomerulosclerotic lesions. Neither tubular nor arterial lesions were exacerbated. The infusion did not influence prostacyclin production or urinary cyclic GMP excretion.
CONCLUSION: A subpressor dose of Ang II infusion impairs renal function with progression of glomerulosclerosis, and these alterations may be due to increased susceptibility of the glomerulus in Dahl-S rats to Ang II-induced injuries. Such a mechanism might underlie a predisposition to hypertension-induced organ damage seen in Dahl-S rats with salt-induced hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759856

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Sodium bicarbonate loading limits tubular cast formation independent of glomerular injury and proteinuria in Dahl salt-sensitive rats.

Authors:  Sarah C Ray; Bansari Patel; Debra L Irsik; Jingping Sun; Hiram Ocasio; Gene R Crislip; Chunhua H Jin; JianKang Chen; Babak Baban; Aaron J Polichnowski; Paul M O'Connor
Journal:  Clin Sci (Lond)       Date:  2018-06-20       Impact factor: 6.124

2.  Consequences of hyperandrogenemia during pregnancy in female offspring: attenuated response to angiotensin II.

Authors:  Noha M Shawky; Carolina Dalmasso; Norma B Ojeda; Yvonne Zuchowski; Nina Stachenfeld; Barbara T Alexander; Jane F Reckelhoff
Journal:  J Hypertens       Date:  2022-04-01       Impact factor: 4.844

3.  Impaired response of regulator of Gαq signaling-2 mRNA to angiotensin II and hypertensive renal injury in Dahl salt-sensitive rats.

Authors:  Yaqiong Wu; Hidenori Takahashi; Etsu Suzuki; Peter Kruzliak; Miroslav Soucek; Yoshio Uehara
Journal:  Hypertens Res       Date:  2015-11-26       Impact factor: 3.872

4.  The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.

Authors:  Yaqiong Wu; Suguru Nakagawa; Hidenori Takahashi; Yukari Kawabata; Etsu Suzuki; Yoshio Uehara
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

5.  A high-salt diet enhances leukocyte adhesion in association with kidney injury in young Dahl salt-sensitive rats.

Authors:  Hidenori Takahashi; Suguru Nakagawa; Yaqiong Wu; Yukari Kawabata; Atsushi Numabe; Yasuo Yanagi; Yasuhiro Tamaki; Yoshio Uehara; Makoto Araie
Journal:  Hypertens Res       Date:  2017-03-16       Impact factor: 3.872

6.  Newly manufactured Marukome MK-34-1 miso with angiotensin-converting enzyme inhibitory activity and its antihypertensive effects in genetic hypertensive rat models.

Authors:  Hiroe Sakuyama Tomari; Misa Uchikawa; Aki Yamazaki; Satomi Hirabayashi; Shoko Yamakawa; Manabu Kitagawa; Minami Yamada; Seiki Itou; Tetsuro Yamamoto; Yoshio Uehara
Journal:  Hypertens Res       Date:  2019-01-10       Impact factor: 3.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.